Abstract
Systemic candidiasis is becoming a major obstacle in the care of debilitated patients, particularly those with primary or iatrogenically induced immune deficiencies. Successful management of this infection requires anticipatory surveillance of the potential victim, and correct interpretation of diagnostically significant signs and symptoms. Predisposing factors as well as clinical, mycological and serological findings that facilitate diagnosis are discussed in the light of 33 cases of systemic candidiasis observed by the authors.It is shown that timely treatment of candidemia raises the chances for survival from 20 to 80%. Toxic side and after effects of amphotericin B can be significantly minimized by holding the dosage to the minimum required to establish and maintain fungistatic serum levels of the drug and by judicious administration and spacing of the intravenous infusions. Guidelines for achieving these aims are presented.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.